| Patents for A61P 39 - General protective or antinoxious agents (19,019) |
|---|
| 03/16/2000 | WO2000013654A2 A carotenoid composition containing phytoene and phytofluene |
| 03/15/2000 | EP0984915A2 Lutein esters having high bioavailability |
| 03/15/2000 | EP0769956B1 USE OF A GnRH ANTAGONIST FOR THE PREPARATION OF A MEDICAMENT FOR THE TREATMENT OF GONADAL-STEROID CONDITIONS |
| 03/09/2000 | WO2000012562A1 HUMAN ANTI-FACTOR IX/IXa ANTIBODIES |
| 03/09/2000 | WO2000012085A1 Ascorbate-isoquercetin compositions |
| 03/09/2000 | WO2000011968A1 ANTIOXIDANT COMPOSITION COMPRISING ACETYL L-CARNITINE AND α-LIPOIC ACID |
| 03/09/2000 | WO1999043791A3 Diisopropyl fluorophosphatase and the utilization and production thereof |
| 03/08/2000 | EP0983300A1 Bpc peptide salts with organo-protective activity, the process for their preparation and their use in therapy |
| 03/08/2000 | EP0983259A1 Tocopherol esters and their cosmetic and pharmaceutical uses |
| 03/08/2000 | EP0983082A1 Novel administration of thrombopoietin |
| 03/08/2000 | CN1246475A Corticotropin release factors antagonistic agent |
| 03/08/2000 | CN1050126C Tri-substituted imidazoles compound, process for preparing it and use and pharmaceutical compositions containing them |
| 03/02/2000 | WO2000011204A2 Homer interacting proteins |
| 03/02/2000 | WO2000010588A2 Epidermal growth factor receptor antagonists for treating hypersecretion of mucus in the lungs |
| 03/02/2000 | WO1999066879A3 Systemic immune activation method using nucleic acid-lipid complexes |
| 03/02/2000 | WO1999055377A9 Polyol-ifn-beta conjugates |
| 03/01/2000 | EP0981374A2 Sustained-release delayed gels |
| 03/01/2000 | EP0981360A1 Method for preventing gastritis using amylin or amylin agonists |
| 03/01/2000 | CN1245706A Face-nourishing oral liquor and its preparation method |
| 03/01/2000 | CN1245688A Oral nutrient lead-expelling powdered granules |
| 02/29/2000 | CA2199613C Indole-2,3-dione-3-oxime derivatives, their preparation and use |
| 02/24/2000 | WO2000009616A1 Biologically active fraction of vegetable melanin, process for its production and its use |
| 02/24/2000 | WO2000009512A2 Bipyridine manganese complexes |
| 02/24/2000 | WO2000009124A1 Pyrrolidine derivatives for vision and memory disorders |
| 02/24/2000 | WO1999045788A8 Food products having enhanced cocoa polyphenol content and processes for producing same |
| 02/24/2000 | CA2341216A1 Bipyridine manganese complexes |
| 02/24/2000 | CA2340702A1 Pyrrolidine derivatives for vision and memory disorders |
| 02/23/2000 | EP0980365A1 Alpha-tocopherol 4-aminobenzoic acid ester compounds and method for preparing the same |
| 02/23/2000 | EP0980349A1 Conjugated linolenic acid-based synthetic triglycerides |
| 02/23/2000 | EP0980240A1 Sustained-release compositions and method for preparing same |
| 02/23/2000 | CN1049659C Corticotropin releasing factor antagonists |
| 02/22/2000 | US6027710 Protects the active ingredient of radiopharmaceuticals against the radiolysis caused by a reaction of the active ingredient with water radicals formed by radiolysis without decomposing the reactive active ingredient (reducible) |
| 02/22/2000 | CA2199614C Fused indole and quinoxaline derivatives, their preparation and use |
| 02/17/2000 | WO2000008013A2 2-substituted-1-piperidyl benzimidazole compounds as orl1-receptor agonists |
| 02/17/2000 | WO2000008007A2 Cyclopentabenzofuran derivatives and their use |
| 02/17/2000 | WO2000007605A1 Use of camptothecin derivatives, with reduced gastrointestinal toxicity |
| 02/17/2000 | WO2000007581A2 Antioxidant, antiproliferous composition, comprising a carnitine and a carotenoid |
| 02/17/2000 | CA2340020A1 Use of camptothecin derivatives, with reduced gastrointestinal toxicity |
| 02/17/2000 | CA2338035A1 Antioxidant, antiproliferous composition, comprising a carnitine and a carotenoid |
| 02/16/2000 | EP0979285A1 Methods to detect granulocytic ehrlichiosis |
| 02/16/2000 | CN1244424A Medicated tea granule |
| 02/16/2000 | CN1244394A Oral preparation with Dimethoate detoxicating function |
| 02/10/2000 | WO2000006171A1 Antioxidant composition and method of treating diseases using same |
| 02/10/2000 | WO2000006091A1 Novel uses of ascorbyl-phosphoryl-cholesterol and compositions for practicing same |
| 02/10/2000 | DE19835324A1 Cyclopentabenzofuran-Derivate und ihre Verwendung Cyclopentabenzofuran derivatives and their use |
| 02/09/2000 | EP0977578A1 Compositions to enhance the cytoprotective effects of polycyclic phenolic compounds through the synergistic interaction with anti-oxidants |
| 02/09/2000 | EP0977574A1 Methods for in vivo reduction of cyanide levels and compositions useful therefor |
| 02/09/2000 | CN1244130A Hapten-carrier conjugates for use in drug-abuse therapy and methods for preparation of same |
| 02/09/2000 | CN1243744A 芦荟组合物 Aloe composition |
| 02/03/2000 | WO2000005270A1 Biocompatible polymers, preparation method and compositions containing same |
| 02/03/2000 | WO2000005216A1 Il-8 receptor antagonists |
| 02/03/2000 | WO2000004878A1 Pharmaceutical composition in particular for preventing and treating mucositis induced by radiotherapy or chemotherapy |
| 02/03/2000 | WO2000004868A2 Libraries of polyhydroxamates and their analogs |
| 02/03/2000 | CA2338741A1 Il-8 receptor antagonists |
| 02/03/2000 | CA2337756A1 Libraries of polyhydroxamates and their analogs |
| 02/02/2000 | EP0975346A1 Pharmaceutical, cosmetic and/or food composition with antioxidant properties |
| 02/01/2000 | US6020510 Cytoprotective compounds |
| 02/01/2000 | US6020326 Method for inhibition of bone growth by anionic polymers |
| 01/27/2000 | WO2000003711A1 Compounds and compositions for treating tissue ischemia |
| 01/27/2000 | WO1999055388A9 Substituted porphyrins |
| 01/27/2000 | CA2337997A1 Compounds and compositions for treating tissue ischemia |
| 01/26/2000 | EP0835251B1 Process for the production of lipoic acid |
| 01/26/2000 | CN1048728C 3-substituted 3H,-2,3-benzodiazepine derivatives, their prepn. and use as medicine |
| 01/25/2000 | US6017763 G-beta-gamma regulated phosphatidylinositol-3' kinase |
| 01/20/2000 | WO2000002860A1 2-aminopyridine erivatives, their use as medicines and pharmaceutical compositions containing them |
| 01/20/2000 | WO2000002841A1 Water-soluble zinc pyruvates or their hydrates, method for the production thereof and their use |
| 01/20/2000 | WO2000002574A1 Powdery preparation for mucosal administration containing polymeric medicine |
| 01/20/2000 | WO2000002543A2 Antihypersensitive combination of valsartan and calcium channel blocker |
| 01/20/2000 | CA2337258A1 2-aminopyridine derivatives, their use as medicines and pharmaceutical compositions containing them |
| 01/19/2000 | EP0972053A1 Novel human serine carboxypeptidase |
| 01/19/2000 | CN1241430A Chinese medicine detoxication preparation of giant gold silkwork |
| 01/19/2000 | CN1241429A Medicine for preventing chronic lead poisoning |
| 01/18/2000 | US6015913 Heating cocoa beans to loosen shell without roasting nib, winnowing nibs from shells, screw pressing nibs to produce cocoa butter and partially defatted cocoa solids |
| 01/18/2000 | US6015912 Treating arthritis, cancer, cardiovascular disorders, skin disorders, ocular disorders, inflammation, gum disease |
| 01/18/2000 | US6015556 Cytotoxic drug therapy |
| 01/13/2000 | WO2000001706A1 N-terminal site selective inhibitors of human angiotensin conversion enzyme (ace) |
| 01/13/2000 | CA2335918A1 N-terminal site selective inhibitors of human angiotensin conversion enzyme (ace) |
| 01/12/2000 | EP0781285B1 Fused indole and quinoxaline derivatives, their preparation and use as glutamate antagonists |
| 01/12/2000 | EP0781284B1 Indole-2,3-dione-3-oxime derivatives, their preparation and use |
| 01/12/2000 | CN1048247C Neuroprotective chroman compounds |
| 01/11/2000 | US6013635 Treatment of C. difficile toxin B associated conditions |
| 01/05/2000 | EP0967987A1 Compositions for treating tumors containing shark cartilage extracts and anti-neoplastic agents |
| 01/05/2000 | CN1240141A Medicinal granule with anti-senility function |
| 12/29/1999 | WO1999066931A1 Use of 1-(aminoalkyl)-3-quinoxaline-2-one derivatives for the preparation of compounds having an antioxidant action |
| 12/29/1999 | WO1999066924A1 Use of nitric oxide scavengers to treat side effects caused by therapeutic administration of sources of nitric oxide |
| 12/29/1999 | WO1999066879A2 Systemic immune activation method using nucleic acid-lipid complexes |
| 12/29/1999 | WO1999055377A3 Polyol-ifn-beta conjugates |
| 12/29/1999 | EP0966426A1 Novel diamine alkylene diacetic or triacetic acid derivatives, preparation method, use in cosmetic and pharmaceutical compositions and compositions containing them |
| 12/29/1999 | EP0966286A1 Attenuation of opioid tolerance by inhibiting inducible nitric oxide synthase pathways in the treatment of pain |
| 12/29/1999 | CN1239944A New pentaerythritol derivatives, their production, and use and intermdiates for their synthesis |
| 12/29/1999 | CN1239892A Use of equilenin as antioxidant |
| 12/29/1999 | CN1239891A Use of 17 '-dihydroequilenin as an antioxidant |
| 12/29/1999 | CN1239890A 17 'alpha'-dihydroequilenin for use as medical antioxidant |
| 12/29/1999 | CA2334973A1 Use of nitric oxide scavengers to treat side effects caused by therapeutic administration of sources of nitric oxide |
| 12/23/1999 | WO1999065501A1 A process for the treatment of organophosphate poisoning |
| 12/23/1999 | CA2332997A1 A process for the treatment of organophosphate poisoning |
| 12/22/1999 | EP0674628B1 Chemopreventive compounds and a preparation method and use thereof |
| 12/15/1999 | CN1238208A Detoxicating instant particles and preparing method thereof |
| 12/14/1999 | US6001961 Cyclic adhesion inhibitors |
| 12/09/1999 | WO1999026583A3 Inhibtion of lipoprotein oxidation |